Evaluation of the sedative effect of sublingual lorazepam versus placebo in patients who are candidate for endoscopy
Phase 2
- Conditions
- candidate for endoscopy.During endoscopic examination
- Registration Number
- IRCT201611039014N130
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 114
Inclusion Criteria
candidate for endoscopy; age of 18 to 55 years.
Exclusion criteria: cardiopulmonary disease; neuropsychological disorders; sensitivity to lorazepam; body mass index above 30.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sedative effect of drug. Timepoint: half hour after treatment. Method of measurement: through physical examination.
- Secondary Outcome Measures
Name Time Method